Combined fertility treatment available

Merck Serono has launched Pergoveris (follitropin alfa/lutropin alfa), indicated for the stimulation of follicular development in women with severe lutinising hormone (LH) and follicle stimulating hormone (FSH) deficiency.

Treatment with Pergoveris should be initiated under the supervision of a physician experienced in the treatment of fertility problems and given as a course of daily injections.


Treatment should be tailored to the individual patient’s response as assessed by measuring follicle size by ultrasound and oestrogen response. A recommended regimen commences with one vial of Pergoveris daily.

Further information: Merck Serono 020 8818 7200

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Stop withdrawal of bipolar disorder treatment, health secretary urged

Stop withdrawal of bipolar disorder treatment, health secretary urged

GPs, pharmacists, psychiatrists and patients are calling...

Contraception advice incentive for GPs linked to 'profound' reduction in abortions

Contraception advice incentive for GPs linked to 'profound' reduction in abortions

A scheme offering GPs financial incentives to provide...